Hydrolyzed Protein Formula in Very-Low-Birth-Weight Infants: Predictors of Use and 20-Month Neurodevelopmental Outcome
In our retrospective analysis of VLBW infants, we did not observe any statistically significant difference in 20-month ND outcomes among infants who received HPF as compared to those who received non-HPF or MBM.
Authors
- Jieun David
- Kousiki Patra (ORCID: https://orcid.org/0000-0002-5038-6613)
- Michelle M. Greene
Institutions
- Endeavor Charter School (US)
- Rush Children's Hospital (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-28
- DOI
- https://doi.org/10.7759/cureus.79828
- Primary Topic
- Infant Nutrition and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00